The Finnish company will supply Open Radio Access Network technology as part of the agreement to roll out a new network in ...
Roche said it will acquire Poseida Therapeutics at $9.00 per share, representing a total equity value of approximately $1.0 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback